Aduhelm (aducanumab) is the first new dementia drug treatment to come to market since 2003.
Featured news and events
In this four part series, Senju Joseph, a carer at the Dementia Respite care centre in Thrissur, India, documents his experience of navigating the catastrophic second COVID-19 wave.
ADI is excited to announce that Paola Barbarino has been appointed as our new CEO. Paola will assume the role on 15 May 2017, after which there will be a period of transition alongside outgoing Executive Director, Marc Wortmann. Marc will be leaving his position after more than ten years…
The government of Indonesia has announced the launch of its national dementia plan during a ceremony at the Ministry of Health.
Smokers have a 45% higher risk of developing dementia than non-smokers according to information published by ADI and WHO.